Multi-Drug Resistance Bacterial Infections in Critically Ill Patients Admitted with COVID-19
Review
[키워드] 95% CI
adjust
affected
affecting
antimicrobial drug
Antimicrobial therapy
Bacterial
bacterial co-infection
Bacterial infection
Co-infection
concomitant increase
contributed
coronavirus disease
COVID-19
COVID-19 outbreak
COVID-19 patient
Critically ill
Critically ill patient
critically ill patients
Culture
death
higher risk
hospital
Hospital acquired infection
Hospital stay
Hospitalization
hospitalized patients
ICU
ICU admission
Ill
incidence
Infection
infections
Influenza
Invasive mechanical ventilation
majority
MDR
morbidity and mortality
MOST
multi-drug resistance
pathogen
Patient
performed
Prevalence
profile
reported
resistance
retrospective
risk factor
SARS-CoV-2
Secondary bacterial infections
Secondary infection
therapy
Ventilated
viral respiratory
with COVID-19
[DOI] 10.3390/microorganisms9081773 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/microorganisms9081773 PMC 바로가기 [Article Type] Review